Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
June 20, 2024 01:00 ET
|
Avextra AG
Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines, is expanding its pharmaceutical development capabilities. Behind SynQube GmbH are the two...
Avextra und SynQube GmbH geben eine strategische Partnerschaft in der Arzneimittelentwicklung mit Cannabinoiden und anderen psychotropen Substanzen bekannt
June 20, 2024 01:00 ET
|
Avextra AG
Avextra, der führende europäische vertikal integrierte Hersteller und Entwickler von Medikamenten auf Cannabisbasis, erweitert nach Abschluss seiner Finanzierungsrunde im ersten Quartal 2024 seine...
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
June 20, 2024 01:00 ET
|
Avextra AG
Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines is expanding its pharmaceutical development capabilities. Behind SynQube GmbH are the two...
Drafting Commercial Contracts for the Pharmaceutical Industry Training Course (London, United Kingdom - July 8-9, 2024)
June 18, 2024 10:53 ET
|
Research and Markets
Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "Drafting Commercial Contracts for the Pharmaceutical Industry Training Course" training has been added to ResearchAndMarkets.com's offering. This...
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
June 18, 2024 08:00 ET
|
Assembly Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases,...
Altus Formulation and Spektar Join Forces in New Specialty Company Spektus Pharma
June 18, 2024 05:00 ET
|
Altus Formulation Inc.
Altus Formulation and Spektar Join Forces in New Specialty Company Spektus Pharma
New venture will develop value-added medicines in the CNS space
Spherix Global Insights Appoints Leigh Anne Siino as Chief Revenue Officer
June 17, 2024 15:43 ET
|
Spherix Global Insights
EXTON, PA, June 17, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry,...
Assembly Biosciences Announces $12.6 Million in Equity Financings
June 17, 2024 08:00 ET
|
Assembly Biosciences, Inc.
— Funding supports advancement of antiviral portfolio, including four candidates in clinical development, and extends cash runway into Q1 2026 — — Anticipated near term interim data read outs include...
Danam Health, Inc. Announces Acquisition of Wood Sage, LLC
June 17, 2024 08:00 ET
|
Danam Health, Inc.
Tampa, FL, June 17, 2024 (GLOBE NEWSWIRE) -- Danam Health, Inc. ( “Danam”) today announced that it completed its acquisition of Wood Sage, LLC (“Wood Sage”). Acquisition of Wood Sage, LLC Danam is...
[Latest] Global Mushroom Market Size/Share Worth USD 146,912.1 Million by 2033 at a 10.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
June 13, 2024 14:40 ET
|
Custom Market Insights
Austin, TX, USA, June 14, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Mushroom Market Size, Trends and Insights By Type of Mushroom (Button Mushrooms,...